1. Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: comparison with osteosarcoma cells. (11th September 2014) Authors: Tacar, Oktay; Indumathy, Sivanjah; Tan, Mei Lin; Baindur‐Hudson, Swati; Friedhuber, Anna M.; Dass, Crispin R. Journal: Journal of pharmacy and pharmacology Issue: Volume 67:Number 2(2015:Feb.) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Co‐nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model. (2nd August 2012) Authors: Tan, Mei Lin; Friedhuber, Anna M.; Dass, Crispin R. Journal: Journal of pharmacy and pharmacology Issue: Volume 65:Number 1(2013:Jan.) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosis. (11th September 2014) Authors: Friedhuber, Anna M.; Chandolu, Vijay; Manchun, Somkamon; Donkor, Osaana; Sriamornsak, Pornsak; Dass, Crispin R. Journal: Journal of pharmacy and pharmacology Issue: Volume 67:Number 1(2015:Jan.) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗